Natriuretic Peptide Receptor B Antibody (N-term) Blocking peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS: 1
- PROTOCOLS
- BACKGROUND
Primary Accession | P20594 |
---|---|
Clone Names | 3031009 |
Gene ID | 4882 |
---|---|
Other Names | Atrial natriuretic peptide receptor 2, Atrial natriuretic peptide receptor type B, ANP-B, ANPR-B, NPR-B, Guanylate cyclase B, GC-B, NPR2, ANPRB |
Target/Specificity | The synthetic peptide sequence used to generate the antibody AP8112a was selected from the N-term region of human ANPB . A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay. |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | NPR2 |
---|---|
Synonyms | ANPRB |
Function | Receptor for the C-type natriuretic peptide NPPC/CNP hormone. Has guanylate cyclase activity upon binding of its ligand. May play a role in the regulation of skeletal growth. |
Cellular Location | Cell membrane; Single-pass type I membrane protein |
Provided below are standard protocols that you may find useful for product applications.
Background
ANPB (natriuretic peptide receptor B) is one of two integral membrane receptors for natriuretic peptides. Both ANPA and ANPB contain five functional domains: an extracellular ligand-binding domain, a single membrane-spanning region, and intracellularly a protein kinase homology domain), an helical hinge region involved in oligomerization, and a carboxyl-terminal guanylyl cyclase catalytic domain. ANPB is the primary receptor for C-type natriuretic peptide (CNP), which upon ligand binding exhibits greatly increased guanylyl cyclase activity.
References
van den Akker, F., J. Mol. Biol. 311(5):923-937 (2001).Hirsch, J.R., et al., J. Am. Soc. Nephrol. 10(3):472-480 (1999).Rehemudula, D., et al., Circ. Res. 84(5):605-610 (1999).Potter, L.R., et al., J. Biol. Chem. 273(25):15533-15539 (1998).Duda, T., et al., Biochemistry 32(6):1391-1395 (1993).
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.